Skybiotech Healthcare Limited has scheduled a board meeting for May 30, 2026, to consider and approve the audited financial results for the quarter and year ended March 31, 2026. The meeting will be held in compliance with Regulation 29(1)(a) of the SEBI (LODR) Regulations, 2015.

The Board of Directors will review the company's financial performance for FY26. Alongside the audited results, the board will also consider the limited review report for the specified period.

Agenda for the Board Meeting

The primary focus of the meeting is the formal approval of the financial statements. The specific transactions to be considered include:

• Audited financial results for the quarter and year ended March 31, 2026.
• Limited review report of the company for the same period.
• Any other business with the permission of the chair.

The meeting notice was signed by Poonam Prakash Rathi, Managing Director of Skybiotech Healthcare Limited.

Skybiotech Healthcare Limited has filed its quarterly compliance certificate with BSE Limited for the quarter ended 31st March, 2026, in accordance with SEBI (Depositories and Participants) Regulations, 2018. The company, formerly known as Kapil Cotex Limited, submitted the mandatory documentation on 09th April, 2026.

Regulatory Compliance Certificate

The certificate was issued under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, which requires companies to report on the dematerialization of physical share certificates. Satellite Corporate Services Pvt. Ltd., serving as the company's Registrar and Share Transfer Agent, provided the compliance certificate dated 06th April, 2026.

Dematerialization Status

The certificate confirms that no physical share certificates were received for dematerialization during the quarter ended 31st March, 2026. This indicates that all existing shares of the company remain in their current form without any conversion from physical to electronic format during the reporting period.

Satellite Corporate Services Pvt. Ltd., a Category-I Registrar with registration number INR000003639, certified that the standard verification processes for dematerialization were maintained, though no physical certificates required processing during Q4 FY26.

Company Information

Skybiotech Healthcare Limited operates under CIN L21001MH1983PLC031114 with its registered office located at Gut No. 05, Gevrai Tanda, Paithan Road, Chh. Sambhaji Nagar (Aurangabad), Maharashtra. The filing was signed by Managing Director Poonam Prakash Rathi (DIN: 01274428), ensuring proper authorization of the regulatory submission.

This compliance filing represents the company's ongoing commitment to meeting SEBI's regulatory requirements for listed entities and maintaining transparency in share transfer operations.